SCHEMBL23590401

SCHEMBL23590401

COc1ccc(CCNO)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.62
▸ LMNA P02545 2/20 0.59
▸ KDM4E B2RXH2 1/20 0.59
▸ F2RL1 P55085 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ CA12 O43570 1/20 0.56
▸ CA1 P00915 1/20 0.56
▸ CA2 P00918 1/20 0.56
▸ CA5A P35218 1/20 0.56
▸ CA9 Q16790 1/20 0.56
▸ CA14 Q9ULX7 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ GLA P06280 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ TAAR1 Q96RJ0 1/20 0.55
▸ CALM1 P0DP23 1/20 0.55
▸ POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951800 0.86 CALM1 (0.59) SMN1; SMN2F2RL1CALM1POLB
SCHEMBL681498 0.81 CHRM2 (0.61) SMN1; SMN2LMNAKDM4EF2RL1HTT
SCHEMBL834551 0.79 TAAR1 (0.73) F2RL1CA12CA1CA2CA9
SCHEMBL6896486 0.79 SMN1; SMN2 (0.58) SMN1; SMN2LMNAKDM4EF2RL1HTT
SCHEMBL18065436 0.79 TAAR1 (0.61) SMN1; SMN2LMNAKDM4EF2RL1HTT
SCHEMBL7528515 0.79 SMN1; SMN2 (0.58) SMN1; SMN2LMNAKDM4EF2RL1HTT
Hydrochloric Acid SCHEMBL1029558 0.79 CHRM2 (0.59) SMN1; SMN2LMNAKDM4EHTTMAPT
SCHEMBL17919369 0.79 SMN1; SMN2 (0.77) SMN1; SMN2LMNAKDM4EMAPTALDH1A1
SCHEMBL8880193 0.79 SMN1; SMN2 (0.57) SMN1; SMN2LMNAKDM4EF2RL1HTT
SCHEMBL157282 0.78 ALDH1A1 (0.62) LMNAF2RL1HTTMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210198220-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198220-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 SMN1; SMN2 1539/4885LMNA 3248/4885KDM4E 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback